Read + Share
Bates ER. In subclinical AF, apixaban vs. aspirin reduced stroke or systemic embolism at
3.5 y, regardless of duration of recent subclinical AF episodes. Ann Intern Med 2025 Jan 7. doi: 10.7326/ANNALS-24-03370.
PMID: 39761588
|
 |
|
Bates ER. In subclinical AF, apixaban vs. aspirin reduced stroke or systemic embolism at
3.5 y, regardless of duration of recent subclinical AF episodes. Ann Intern Med 2025 Jan 7. doi: 10.7326/ANNALS-24-03370.
PMID: 39761588
|
|
|
|